Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Abbott Laboratories, consolidated cash flow statement (quarterly data)

US$ in millions

3 months ended:	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net earnings	1,644)	1,779)	1,325)	9,229)	1,646)	1,302)	1,225)	1,594)	1,436)	1,375)	1,318)	1,033)	1,435)	2,018)	2,447)	1,989)	2,100)	1,189)	1,793)	2,162)	1,232)	537)	564)
Depreciation	371)	357)	336)	342)	331)	334)	333)	332)	328)	302)	315)	311)	317)	315)	311)	369)	327)	370)	425)	358)	298)	272)	267)
Amortization of intangible assets	420)	420)	420)	465)	470)	471)	472)	481)	496)	498)	491)	496)	498)	507)	512)	514)	520)	504)	509)	508)	510)	553)	561)
Share-based compensation	120)	142)	289)	111)	117)	141)	304)	114)	117)	132)	281)	115)	123)	142)	305)	106)	114)	132)	288)	98)	100)	115)	233)
Trade receivables	(202)	(410)	(262)	(158)	(57)	(325)	(151)	68)	(461)	(196)	233)	341)	530)	(188)	(751)	(189)	(394)	35)	165)	(581)	(470)	231)	(104)
Inventories	213)	3)	(255)	235)	220)	(103)	(410)	295)	140)	(248)	(419)	(189)	(194)	(476)	(554)	15)	71)	(5)	(537)	345)	149)	(550)	(437)
Other, net	221)	(244)	(436)	(7,356)	(22)	140)	(748)	154)	(179)	(660)	(1,076)	219)	71)	92)	(205)	263)	(37)	(97)	(6)	908)	247)	164)	(369)
Adjustments to reconcile net earnings to net cash from operating activities	1,143)	268)	92)	(6,361)	1,059)	658)	(200)	1,444)	441)	(172)	(175)	1,293)	1,345)	392)	(382)	1,078)	601)	939)	844)	1,636)	834)	785)	151)
Net cash from operating activities	2,787)	2,047)	1,417)	2,868)	2,705)	1,960)	1,025)	3,038)	1,877)	1,203)	1,143)	2,326)	2,780)	2,410)	2,065)	3,067)	2,701)	2,128)	2,637)	3,798)	2,066)	1,322)	715)
Acquisitions of property and equipment	(496)	(502)	(484)	(720)	(556)	(533)	(398)	(755)	(560)	(507)	(380)	(610)	(467)	(379)	(321)	(614)	(461)	(413)	(397)	(679)	(496)	(642)	(360)
Acquisitions of businesses and technologies, net of cash acquired	(55)	(30)	—)	—)	—)	—)	—)	—)	(51)	(826)	—)	—)	—)	—)	—)	—)	(172)	—)	(15)	(10)	—)	(32)	—)
Proceeds from business dispositions	—)	—)	—)	—)	—)	1)	—)	—)	—)	40)	—)	—)	—)	48)	—)	—)	86)	48)	—)	10)	—)	48)	—)
(Purchases) sales of other investment securities, net	90)	(52)	8)	(150)	(40)	77)	(28)	(71)	(38)	79)	(86)	(30)	(21)	59)	(41)	(69)	(108)	95)	(14)	(58)	17)	4)	(36)
Other	4)	2)	6)	4)	2)	2)	1)	2)	15)	1)	4)	8)	4)	8)	2)	12)	4)	6)	4)	6)	7)	3)	3)
Net cash used in investing activities	(457)	(582)	(470)	(866)	(594)	(453)	(425)	(824)	(634)	(1,213)	(462)	(632)	(484)	(264)	(360)	(671)	(651)	(264)	(422)	(731)	(472)	(619)	(393)
Net borrowings (repayments) of short-term debt and other	8)	(16)	(36)	26)	44)	(43)	(127)	111)	(61)	13)	(42)	10)	24)	5)	8)	(197)	(27)	(4)	24)	(1)	(28)	(20)	51)
Proceeds from issuance of long-term debt	—)	2)	1)	1)	1)	221)	—)	1)	—)	1)	—)	—)	1)	6)	—)	4)	—)	—)	—)	1)	1)	1,279)	—)
Repayments of long-term debt	(501)	(1)	(1,001)	(640)	(2)	(18)	—)	(1,051)	(1,445)	(2)	—)	—)	(1)	(1)	(751)	(3)	(40)	(3)	(2)	(1)	(1,330)	(1)	(1)
Purchases of common shares	(305)	(6)	(280)	(315)	(751)	(3)	(226)	(259)	(2)	(426)	(540)	(685)	(798)	(5)	(2,307)	(974)	(579)	(471)	(275)	(161)	(2)	(4)	(236)
Proceeds from stock options exercised	69)	35)	287)	25)	92)	13)	134)	34)	56)	15)	62)	41)	57)	10)	59)	82)	70)	17)	86)	16)	83)	57)	89)
Dividends paid	(1,031)	(1,029)	(1,026)	(958)	(960)	(961)	(957)	(888)	(888)	(890)	(890)	(823)	(826)	(828)	(832)	(798)	(801)	(803)	(800)	(641)	(639)	(642)	(638)
Other	—)	(82)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	(11)	—)
Net cash used in financing activities	(1,760)	(1,097)	(2,055)	(1,861)	(1,576)	(791)	(1,176)	(2,052)	(2,340)	(1,289)	(1,410)	(1,457)	(1,543)	(813)	(3,823)	(1,886)	(1,377)	(1,264)	(967)	(787)	(1,915)	658)	(735)
Effect of exchange rate changes on cash and cash equivalents	(10)	51)	24)	(83)	36)	(13)	(36)	25)	(29)	(27)	8)	51)	(96)	(71)	(6)	(13)	(29)	4)	(32)	78)	38)	25)	(70)
Net increase (decrease) in cash and cash equivalents	560)	419)	(1,084)	58)	571)	703)	(612)	187)	(1,126)	(1,326)	(721)	288)	657)	1,262)	(2,124)	497)	644)	604)	1,216)	2,358)	(283)	1,386)	(483)

Net Earnings: Net earnings displayed volatility but generally exhibited strong performance with notable peaks in late 2024. Following an initial peak at the end of 2020, earnings fluctuated with a downward trend into late 2022, followed by a recovery and subsequent fluctuations. The highest value emerges significantly in March 2025, suggesting an exceptional quarter.
Depreciation and Amortization of Intangible Assets: Depreciation steadily increased over the analyzed period, indicating consistent capital asset usage or additions. Amortization of intangible assets showed a gradual decline, reflecting either decreasing amortizable intangible assets or changes in amortization schedules.
Share-based Compensation: Share-based compensation presented cyclical variations, with notable spikes approximately every four quarters, potentially linked to strategic employee incentives or stock option grants aligned with annual cycles.
Working Capital Components: Trade Receivables and Inventories: Trade receivables and inventories exhibited substantial volatility, with frequent swings between positive and negative values. This fluctuation suggests inconsistent collection patterns and inventory management challenges or deliberate working capital adjustments to support operational needs.
Other, Net: The "Other, net" category showed erratic and sometimes substantial negative values, notably a major impairment or unusual charge in late 2024. These irregularities indicate episodic one-time items or adjustments significantly impacting the cash flow from operations or other parts of the balance sheet.
Adjustments to Reconcile Net Earnings to Operating Cash Flows: This metric saw large positive values in 2020 and early 2021, corresponding with high net earnings periods. However, it turned sharply negative in specific quarters, reflecting non-cash expenses, working capital changes, or other operational adjustments that impact cash generation consistency.
Net Cash from Operating Activities: Operating cash flows closely tracked net earnings trends with some decoupling due to working capital effects and other adjustments. While substantial cash inflows occurred in early periods and certain quarters of 2024, some quarters reflected more moderate cash generation, suggesting operational cash efficiency varied.
Investing Activities: Investment in property and equipment demonstrated a consistent outflow, generally increasing in magnitude toward later periods, indicating ongoing capital expenditure commitments. Acquisitions of businesses and technologies occurred sporadically, with notable activity in mid-2023. Overall, investing cash flows consistently represented cash outflows, underscoring an active investment strategy.
Financing Activities: Financing cash flows were marked by significant repurchases of common shares, especially large in early 2022, indicating an aggressive share buyback program during that period. Dividends paid consistently increased each year, reflecting a stable or growing dividend policy. Debt repayments and issuances show active management of debt levels, with large repayments in 2021 and 2022 and modest borrowings generally throughout.
Effect of Exchange Rate Changes: Exchange rate effects on cash showed volatility but lacked a directional trend, indicating periodic foreign exchange gains or losses that moderately impacted cash balances.
Net Change in Cash and Cash Equivalents: Cash levels were volatile, with significant increases particularly in the first half of 2020 and intermittent decreases thereafter. Some quarters experienced large declines, particularly in early 2022 and late 2023, correlating with high investing and financing outflows. Overall, cash management appears actively balanced among operational inflows and investing/financing needs.

Download chart

Abbott Laboratories (NYSE:ABT)

Cash Flow Statement Quarterly Data

Cash Flow Statement
Quarterly Data